Quarterly report pursuant to Section 13 or 15(d)

Condensed Balance Sheets

v3.21.2
Condensed Balance Sheets - USD ($)
Sep. 30, 2021
Dec. 31, 2020
Current assets:    
Cash and cash equivalents $ 958,654 $ 47,090
Prepaid expenses 948,973
Total current assets 1,907,627 47,090
Investments held in Trust Account 862,533,417
Deferred offering costs associated with initial public offering 282,875
Total Assets 864,441,044 329,965
Current liabilities:    
Accounts payable 267,756 117,911
Accrued expenses 552,893 21,614
Franchise tax payable 147,447 609
Note payable – related party 170,000
Total current liabilities 968,096 310,134
Derivative warrant liabilities 33,363,960
Deferred underwriting commissions 30,187,500
Promissory note – related party 1,384,970
Total liabilities 65,904,526 310,134
Commitments and Contingencies
Class A common stock subject to possible redemption, $0.0001 par value; 86,250,000 and -0- shares issued and outstanding at $10.00 per share redemption price at September 30, 2021 and December 31, 2020, respectively 862,500,000
Stockholders’ Equity (Deficit):    
Preferred stock, $0.0001 par value; 3,000,000 shares authorized; none issued and outstanding
Class A common stock, $0.0001 par value; 300,000,000 shares authorized at September 30, 2021 and December 31, 2020
Class B common stock, $0.0001 par value; 30,000,000 shares authorized; 21,562,500 shares issued and outstanding at September 30, 2021 and December 31, 2020 2,156 2,156
Additional paid-in capital 22,844
Accumulated deficit (63,965,638) (5,169)
Total stockholders’ equity (deficit) (63,963,482) 19,831
Total Liabilities, Class A Common Stock Subject to Possible Redemption and Stockholders’ Equity (Deficit) $ 864,441,044 $ 329,965